COCH Envoy Medical, Inc.: institutional ownership and insider trading

35 funds reported holding $14.3M of Envoy Medical, Inc. in their latest 13F filings; in Q2 2026 funds net bought $355K, with 6 new positions and 7 funds selling out; over the last 12 months insiders bought $8.17M and sold $0 on the open market; over its last four quarters it reported revenue of $207K and net income of −$23.4M.

COCH revenue and earnings

Largest institutional holders of COCH

  1. Nantahala Capital Management, LLC — $5.96M
  2. Bleichroeder LP — $4.95M
  3. VANGUARD CAPITAL MANAGEMENT LLC — $697K
  4. DSG Capital Advisors, LLC — $474K
  5. GEODE CAPITAL MANAGEMENT, LLC — $429K
  6. Focus Partners Wealth — $337K
  7. VANGUARD FIDUCIARY TRUST CO — $235K
  8. VANGUARD GROUP INC — $230K
  9. UBS Group AG (UBS) — $151K
  10. Arcus Capital Partners, LLC — $149K

Recent COCH insider trades

5%+ owners

Who owns the most COCH stock?

The largest institutional holders of Envoy Medical, Inc. in the latest 13F filings are Nantahala Capital Management, LLC ($5.96M), Bleichroeder LP ($4.95M), VANGUARD CAPITAL MANAGEMENT LLC ($697K).

Are insiders buying or selling COCH?

Over the last 12 months insiders bought $8.17M and sold $0 of Envoy Medical, Inc. stock on the open market (SEC Form 4).

What was COCH's revenue last quarter?

Envoy Medical, Inc. reported revenue of $51.0K for the quarter ended June 30, 2026, with net income of −$5.98M.

All COCH 13F holders · All COCH insider trades